The forward P/E of 25.67 and PEG of 1.01 suggest the market is not paying an extreme multiple for expected earnings growth, though a PEG near 1 leaves little margin for error if growth normalizes. Relative to JCI at 49.98 and AAON at 42.19, Trane trades at a discount on trailing earnings, which may indicate the market sees its growth as less speculative than peers with higher multiples. Investors should monitor whether the 2026Q3 growth spike persists, since the valuation depends on it more than on the current margin profile.

Gross margin has held in a narrow 34.1% to 37.6% band, which points to stable pricing power and cost pass-through rather than a structural expansion. The gap between operating and gross margin movement indicates that SG&A discipline and volume leverage, not gross margin gains, drove the recent recovery. Net margin of 15.5% compares favorably with JCI at 13.9% and CARR at 6.8%, although the lead over LII at 15.1% is marginal.

The ROE of 11.8% overstates capital efficiency relative to ROIC, consistent with a balance sheet carrying $7.1B in goodwill that dilutes returns on total capital. Compared with its own 2024 readings near 7.0%, the current ROIC level indicates genuine improvement, though not yet a clear compounding trajectory. The gap between ROE and ROIC warrants further investigation into how much acquisition-driven capital sits behind the reported returns.

The improvement in D/E is partly driven by equity build, and the D/EBITDA of 3.15 in 2026Q3 versus 5.26 in 2026Q1 reflects both debt reduction and earnings recovery. Total debt has changed little since 2026Q1, suggesting the deleveraging pace has moderated and further gains depend on earnings growth rather than repayment. Coverage ratios at this level suggest low near-term refinancing pressure based on reported figures, though the analysis does not capture covenant terms or maturity schedules.